• london biotech banner
  • Dermatology June 24 Conference
MedEdge MEA MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
Reading: What is HMPV? A new virus or global threat? quick answers
Share
Notification
  • london biotech banner
  • Dermatology June 24 Conference
MedEdge MEA
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
Have an existing account? Sign In
MedEdge MEA > ME Explained > What is HMPV? A new virus or global threat? quick answers
ME Explained

What is HMPV? A new virus or global threat? quick answers

Harshad Hussain B
Harshad Hussain B
Published: January 4, 2025
Share
5 Min Read
Corona virus on globe with a person wearing mask
SHARE

Reports appearing from China point to a noticeable rise in respiratory infections, raising concerns about overcrowded hospitals and increasing pressure on healthcare facilities. The surge in cases is widely speculated to be associated with Human Metapneumovirus (HMPV), a virus known to cause respiratory illnesses, particularly in young children and older adults. While social media platforms have been flooded with claims depicting an escalating crisis, there has been no formal acknowledgment of an emergency situation from Chinese authorities or international health organizations. The situation continues to draw attention as health experts monitor developments closely.

Contents
What is Human Metapneumovirus (HMPV)?First Case of HMPVSymptoms of HMPVWho should be concerned about HMPV?Possible HMPV outbreak in China: What’s Happening?Is HMPV the new COVID-19?

What is Human Metapneumovirus (HMPV)?

The virus known as human metapneumovirus (HMPV) typically produces symptoms that resemble the common cold. It normally results in minor upper respiratory tract infections, but occasionally it can worsen long-term lung diseases like COPD or create more significant issues like pneumonia or flare-ups of asthma. Infections with HMPV are more frequent in the winter and early spring.

The majority of HMPV cases occur before the age of five. While recurrent infections are possible, they are often less severe than the first ones.

First Case of HMPV

Human metapneumovirus (HMPV) was first discovered in 2001 in the Netherlands by Bernadette G. van den Hoogen and her team. It was found in respiratory samples from 28 children. Early tests, including antibody-based and PCR methods, could not identify the virus because they only detected known respiratory viruses. Researchers later used advanced molecular techniques to study its genetic makeup and found it was closely related to avian pneumovirus, leading to its name, human metapneumovirus.

Symptoms of HMPV

Most people with HMPV experience mild upper respiratory symptoms similar to the common cold, such as cough, a runny or congested nose, sore throat, and fever. In more severe cases, symptoms may include wheezing, breathing difficulties, and asthma flare-ups. Some patients may also develop secondary lower respiratory infections like bronchiolitis, bronchitis, or pneumonia, which could require further medical attention and care.

Who should be concerned about HMPV?

Hospitalization for HMPV is most likely to occur in children younger than two years old. Severe sickness from HMPV is more likely to occur in those with underlying illnesses such as asthma, bronchopulmonary dysplasia, congenital heart disease, a history of premature delivery, or compromised immune systems. Serious problems are also more likely to occur in those over 65 who have compromised immune systems or persistent heart or lung diseases like asthma and COPD.

Also Read : ‘Disease X’ Alert: What is the risk and how do we prepare?

Possible HMPV outbreak in China: What’s Happening?

The Chinese Center for Disease Control and Prevention (CDC) has acknowledged a recent outbreak of HMPV in China, as reported by state-run media. A spokesperson for the agency downplayed the severity of the outbreak, explaining that an increase in cases of HMPV, influenza, rhinovirus, and mycoplasma pneumonia is typical during the winter months. The spokesperson also stated that the spread of COVID-19 and other respiratory illnesses remains “at a low level.” The World Health Organization (WHO) has not yet commented on the situation, and neither WHO nor Chinese authorities have declared a state of emergency.

Is HMPV the new COVID-19?

While HMPV and COVID-19 are not exactly the same, they do have certain similarities. HMPV usually causes symptoms like cough, fever, congestion of the nose, and shortness of breath that are comparable to the common cold. Young children, the elderly, and those with compromised immune systems may experience more severe symptoms, which could result in pneumonia or bronchitis.
Compared to COVID-19, HMPV is typically less severe and spreads on a smaller scale, despite being contagious and spreading by respiratory droplets. Although widespread worry is unnecessary, it’s always a good idea to follow simple hygiene precautions like washing your hands frequently and wearing masks in public areas to stop the spread of the disease.

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article ovarian cancer GSK announces FIRST trial met its primary endpoint of progression free survival in ovarian cancer
Next Article Dubai DUPHAT 2025 Starts Tomorrow, Highlighting Pharma Innovations in Dubai

Recent Posts

  • WCM-Q Earns Global Recognition as Diabetes Center of Excellence by IDF
  • AbbVie and ADARx Announce $335 Million Collaboration to Develop Cutting-Edge RNA Therapeutics
  • NATIONAL MS SOCIETY ANNOUNCES 2025 RESEARCH GRANT AWARDEES
  • Japan to Begin Clinical Trials for Artificial Blood in 2025
  • Future Trends in RegTech : How AI is Transforming Regulatory Authorities and Processes
  • Dermatology expo rome
  • LifeSpin
Two Point Five Logo white
  • About Us
  • Terms and Conditions
  • Privacy Policy
  • Submit Your Story
  • Contact Us
  • MediaKit
Reading: What is HMPV? A new virus or global threat? quick answers
Share

Published by Two Point Five Media FZCO

  • About Us
  • Terms and Conditions
  • Privacy Policy
  • Submit Your Story
  • Contact Us
  • MediaKit
Reading: What is HMPV? A new virus or global threat? quick answers
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?